Respiratory

Respiratory Inhaler

Asthma and chronic obstructive pulmonary disease (COPD) are among the most common chronic respiratory diseases and can cause symptoms such as shortness of breath, wheezing, repeated coughing and chest tightness.

About the product

Asthma and chronic obstructive pulmonary disease (COPD) are among the most common chronic respiratory diseases and can cause symptoms such as shortness of breath, wheezing, repeated coughing and chest tightness. Persistent airway inflammation and narrowing of the air passages are the main causes of symptoms and respiratory exacerbations.

Proper control of these diseases requires regular maintenance treatment to reduce airway inflammation, preserve lung function and reduce the frequency of exacerbations. Combination inhalers such as Strila, with two active components, act simultaneously to reduce inflammation and open the airways, helping to control the disease over the long term.

  • Product introduction and information

The combination of budesonide and formoterol controls the underlying inflammation of the disease and improves airflow in the respiratory passages.

Dose combinations

Strila is available in three strengths

  • Strila 80/4.5 mcgBudesonide 80 mcgFormoterol 4.5 mcg
  • Strila 160/4.5 mcgBudesonide 160 mcgFormoterol 4.5 mcg
  • Strila 320/9 mcgBudesonide 320 mcgFormoterol 9 mcg

Age group: depending on the prescribed dose and the patient's condition, it can be used in patients with asthma and COPD as directed by the physician.

Using dry powder inhaler (DPI) manufacturing technology, Ofogh Darou has produced Strila to give patients access to advanced respiratory treatments.

Manufacturing inhaled products requires great precision in controlling particle size, ensuring uniform distribution of the active ingredient and ensuring that the right amount of medicine reaches the airways.

Domestic production of Strila, in addition to increasing patients' access to standard treatment, plays an important role in reducing dependence on imported products and in developing the country's pharmaceutical technology.

Use and audience

Indications

Strila is used in the following cases

Maintenance treatment of asthma in patients who need combination treatment with an inhaled corticosteroid and a LABA.

Control of symptoms and reduction of asthma exacerbations.

Maintenance treatment of chronic obstructive pulmonary disease (COPD).

Helps improve lung function and reduce respiratory symptoms such as shortness of breath and wheezing.

  • How the drug works

Through the complementary action of its two active ingredients, Strila provides better control of respiratory diseases.

Budesonide

By reducing inflammation in the airways, budesonide

Reduces chronic inflammation of the respiratory passages.

Reduces airway sensitivity.

Reduces the likelihood of asthma attacks.

Formoterol

By stimulating beta-2 receptors in the smooth muscle of the airways, formoterol

Relaxes the muscles around the respiratory passages.

Opens the air passage wider.

Reduces the feeling of shortness of breath.

The combination of these two ingredients means that

Long-term control of respiratory symptoms improves.

The underlying inflammation of the disease is reduced.

Lung function and patients' quality of life are enhanced.

  • Important points before and during use

Strila must only be used with the dedicated inhaler device.

Capsules must not be swallowed.

Correct use of the device is essential for receiving the right amount of medicine.

The medicine must be used regularly as directed by the physician.

After use, rinse the mouth with water to reduce the chance of throat irritation or oral fungal infection.

Warnings

  • Possible side effects

Common: throat irritation, dry mouth, hoarseness, cough, headache

Uncommon: hand tremor, palpitations, insomnia, muscle cramps

Rare and important: severe allergic reaction including swelling of the face, lips or tongue

  • Severe shortness of breath after use

If symptoms of a severe allergic reaction occur, the patient should see a physician immediately.

  • Storage conditions

Store at room temperature and away from direct light.

Protect from moisture.

Keep capsules in the original pack until use.

Keep out of reach of children.

  • Practical advice for patients

Regular use of the medicine, even when symptoms have eased, is essential for controlling the disease.

Learn the correct way to use the inhaler device from your physician or pharmacist.

Rinse your mouth with water after each use.

Avoid irritants such as cigarette smoke, air pollution and allergens as far as possible.

Regular follow-up of respiratory status and lung function helps control the disease better.

Full specifications

Frequently asked questions

01Is Strila used to treat a sudden asthma attack?
Strila is a controller and maintenance medicine, and it must be used as directed by the physician. In acute respiratory attacks the patient may need a fast-acting medicine.
02What should I do if I forget a dose of the medicine?
Take the missed dose as soon as you remember; but if it is almost time for the next dose, do not double the medicine.
03Can Strila be used during pregnancy or breastfeeding?
Use of this medicine during pregnancy or breastfeeding should be only on a physician's advice.